Developing high-quality medicine is a resource-intense endeavor that requires collaboration across Novo Nordisk. Novo Nordisk aimed to scale a pipeline of drug discovery, development, and data science capabilities with AI and machine learning. In partnership with Microsoft Research, the teams built a Novo Nordisk AI platform on Azure AI and data stacks. Novo Nordisk amplified its culture of innovation by leveraging Microsoft Azure platform's AI capabilities across many use cases. The teams recently published initial results with predictive AI models for advanced risk detection in cardiovascular diseases, including an algorithm that can predict patients' cardiovascular risk better than the best clinical standards. Read this case study for lessons learned.
Many employees aren't equipped to evaluate or question the outputs they receive from AI. This article from MIT Sloan explains the risk of "rubber-stamping" AI outputs without understanding the rationale behind them, and outlines strategies for building explainability into workplace systems. Read the article to learn how your organization can build a culture that embraces AI without surrendering critical thinking. For guidance on making AI a trusted tool, contact Metisc. Read More...
Comments
Post a Comment